AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (February 13, 2008). doi:10.1152/ajprenal.00483.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/4/F982    most recent
00483.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S.-Y.
Right arrow Articles by Kim, U.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S.-Y.
Right arrow Articles by Kim, U.-H.
Submitted on October 16, 2007
Accepted on February 5, 2008

Molecular Mechanism of ADP-Ribosyl Cyclase Activation in Angiotensin II Signaling in Murine Mesangial Cells

Seon-Young Kim1, Rukhsana Gul1, So-Young Rah1, Suhn Hee Kim2, Sung Kwang Park3, Mie-Jae Im1, Ho Jeong Kwon4, and Uh-Hyun Kim1*

1 Biochemistry, Chonbuk National University Medical School, Jeonju, Chonbuk , Korea, Republic of
2 Physiology, Chonbuk National University Medical School, Jeonju, Chonbuk , Korea, Republic of
3 Internal Medicine, Chonbuk National University Medical School, Jeonju, Chonbuk , Korea, Republic of
4 Biotechnology, College of Engineering, Yonsei University, Seoul, Seoul, Korea, Republic of

* To whom correspondence should be addressed. E-mail: uhkim{at}chonbuk.ac.kr.

ADP-ribosyl cyclase (ADPR-cyclase) produces a Ca2+-mobilizing second messenger, cyclic ADP-ribose (cADPR) from NAD+. In this study, we investigated molecular basis of ADPR-cyclase activation and the following cellular events in angiotensin II (AngII) signaling in mouse mesangial cells (MMCs). Treatment of MMCs with AngII induced an increase in intracelluar Ca2+ concentrations through a transient Ca2+ release via IP3 receptor and a sustained Ca2+ influx via L-type Ca2+ channels. The sustained Ca2+ signal, but not the transient Ca2+ signal, was blocked by a cADPR antagonistic analog, 8-Br-cADPR and an ADPR-cyclase inhibitor, 4,4’-dihydroxyazobenzene (DHAB). Supporting the results, AngII stimulated cADPR production in a time dependent manner, and DHAB inhibited AngII-induced cADPR production. Application of pharmacological inhibitors revealed that activation of ADPR-cyclase by AngII involved AngII type 1 receptor, phosphoinositide 3-kinase, protein tyrosine kinase, and phospolipase C-{gamma}1. Moreover, DHAB as well as 8-Br-cADPR abrogated AngII-mediated Akt phosphorylation, nuclear translocation of nuclear factor of activated T-cell, and uptake of [3H]-thymidine and [3H]-leucine in MMCs. These results demonstrate that ADPR-cyclase in MMCs plays a pivotal role in AngII signaling for cell proliferation and protein synthesis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.